Laformin GV 2mg/500mg/0.2mg Tablet ER
By Laformin GV
Rx
10 Tablet ER in a Strip

Composition
Glimepiride(2mg) + Metformin(500mg) + Voglibose(0.2mg)

Manufacturer - La Renon Healthcare Pvt Ltd
Behind Rajpath Club, Kensville Road, Opp. Infostretch Building, Off S.G. Highway, Ahmedabad- 380059, Gujarat- India

Expires on or after
February, 2026

liver
When using Laformin GV 2mg/500mg/0.2mg Tablet ER, it is important to be cautious if you have liver disease. Your doctor may need to adjust the dose of the medication. Typically, Laformin GV 2mg/500mg/0.2mg Tablet ER is initiated at a low dose for individuals with mild to moderate liver disease. It is not advisable to use this medication if you have severe liver disease. Please consult your doctor for personalized guidance on the appropriate use of Laformin GV 2mg/500mg/0.2mg Tablet ER in case of liver issues.

kidney
Laformin GV 2mg/500mg/0.2mg Tablet ER may not be safe for use in patients with kidney disease. It is not recommended for those with severe kidney disease. Please consult your doctor before taking this medication.

alcohol
It is not safe to drink alcohol while taking Laformin GV 2mg/500mg/0.2mg Tablet ER. Mixing alcohol with this medication can be harmful.

driving
When taking Laformin GV 2mg/500mg/0.2mg Tablet ER, be cautious while driving as your blood sugar levels can impact your ability to drive. Avoid driving if you experience low or high blood sugar symptoms.

pregnancy
Laformin GV 2mg/500mg/0.2mg Tablet ER may not be safe to use during pregnancy. Animal studies have shown potential harm to the developing baby. Consult your doctor for a thorough evaluation of benefits and risks before using this medication during pregnancy.

breastfeeding
Caution is advised while breastfeeding as Laformin GV 2mg/500mg/0.2mg Tablet ER is likely unsafe. Limited human data indicates potential harm to the baby through breastmilk passage.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹170
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024